Jacqueline Zummo, Ph.D.

Jacqueline Zummo, Ph.D.

Chief R&D OfficeratProtara Therapeutics· In proxies 2022–2025

Pay in FY2025+14% from the year before · Protara Therapeutics stock +0.9% the same year

Jacqueline Zummo, Ph.D. was paid $1.4M in FY2025 (Dec), up 14%. Protara Therapeutics stock rose 0.9% that year.

Pay$100 in the stock at the end of FY21 → $79
Pay is from the Summary Compensation Table of each Protara Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Protara TherapeuticsPublic company · 4 yr
    • Chief R&D Officer2022 – Present · 4 yrStock in role -62%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?